ASSET | QUARTER | % RETURN |
---|---|---|
QXO (QXO) | Q4 2023 | 416.92% |
Immunitybio (IBRX) | Q4 2023 | 195.29% |
Cytokinetics (CYTK) | Q4 2023 | 184.37% |
Scholar Rock (SRRK) | Q4 2023 | 166.67% |
CleanSpark (CLSK) | Q4 2023 | 164.73% |
Affirm (AFRM) | Q4 2023 | 132.01% |
Coinbase Global (COIN) | Q4 2023 | 121.41% |
Triumph (TGI) | Q4 2023 | 117.02% |
Xometry (XMTR) | Q4 2023 | 111.73% |
Arvinas (ARVN) | Q4 2023 | 111.4% |
TG Therapeutics (TGTX) | Q4 2023 | 102.13% |
Rhythm Pharmaceuticals (RYTM) | Q4 2023 | 100.57% |
Gap (GAP) | Q4 2023 | 98.92% |
OppFi (OPFI) | Q4 2023 | 98.45% |
Spirit Aerosystems (SPR) | Q4 2023 | 97.76% |
Edgewise Therapeutics (EWTX) | Q4 2023 | 90.92% |
Snap (SNAP) | Q4 2023 | 90.87% |
Liquidia Technologies (LQDA) | Q4 2023 | 89.75% |
Aurora Innovation (AUR) | Q4 2023 | 87.55% |
Grupo Supervielle (SUPV) | Q4 2023 | 86.24% |
Blueprint Medicines (BPMC) | Q4 2023 | 84.48% |
Kymera Therapeutics (KYMR) | Q4 2023 | 83.83% |
Twist Bioscience (TWST) | Q4 2023 | 83.57% |
Foot Locker (FL) | Q4 2023 | 83.03% |
Iris Energy (IREN) | Q4 2023 | 82.86% |